The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Gastrointestinal Drugs Market Research Report 2025

Global Gastrointestinal Drugs Market Research Report 2025

Publishing Date : Mar, 2025

License Type :

Report Code : 1794849

No of Pages : 94

Ask Your Query

Report Description
Table of Content

Synopsis

Gastrointestinal (GI) disorders include functional bowel diseases such as irritable bowel syndrome (IBS) and inflammatory bowel diseases such as Crohn's disease (CD) and colitis. Some gastrointestinal drug can control or moderate the symptoms of gastrointestinal disorders.

The global Gastrointestinal Drugs market was valued at US$ 34710 million in 2023 and is anticipated to reach US$ 43470 million by 2030, witnessing a CAGR of 3.2% during the forecast period 2024-2030.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Gastrointestinal Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gastrointestinal Drugs.

Report Scope

The Gastrointestinal Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Gastrointestinal Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Gastrointestinal Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company

AstraZeneca
Sanofi
Bayer
Pfizer
GlaxoSmithKline
Teva
Zeria (Tillotts)
Perrigo
Boehringer Ingelheim
Purdue Pharma
C.B. Fleet
Abbott
Jiangzhong
Xian-Janssen

Segment by Type

Prescription Gastrointestinal Drug
OTC Gastrointestinal Drug

Segment by Application

Chronic Gastritis
Functional Dyspepsia
Peptic Ulcer
Acute Gastroenteritis
Other

Consumption by Region

North America (United States, Canada)
Europe (Germany, France, U.K., Italy, Russia)
Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
Latin America (Mexico, Brazil, Argentina)
Middle East & Africa (Turkey, Saudi Arabia, UAE)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Gastrointestinal Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Gastrointestinal Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Index

1 Gastrointestinal Drugs Market Overview
1.1 Product Overview and Scope of Gastrointestinal Drugs
1.2 Gastrointestinal Drugs Segment by Type
1.2.1 Global Gastrointestinal Drugs Market Value Comparison by Type (2024-2030)
1.2.2 Prescription Gastrointestinal Drug
1.2.3 OTC Gastrointestinal Drug
1.3 Gastrointestinal Drugs Segment by Application
1.3.1 Global Gastrointestinal Drugs Market Value by Application: (2024-2030)
1.3.2 Chronic Gastritis
1.3.3 Functional Dyspepsia
1.3.4 Peptic Ulcer
1.3.5 Acute Gastroenteritis
1.3.6 Other
1.4 Global Gastrointestinal Drugs Market Size Estimates and Forecasts
1.4.1 Global Gastrointestinal Drugs Revenue 2019-2030
1.4.2 Global Gastrointestinal Drugs Sales 2019-2030
1.4.3 Global Gastrointestinal Drugs Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Gastrointestinal Drugs Market Competition by Manufacturers
2.1 Global Gastrointestinal Drugs Sales Market Share by Manufacturers (2019-2024)
2.2 Global Gastrointestinal Drugs Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Gastrointestinal Drugs Average Price by Manufacturers (2019-2024)
2.4 Global Gastrointestinal Drugs Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Gastrointestinal Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Gastrointestinal Drugs, Product Type & Application
2.7 Gastrointestinal Drugs Market Competitive Situation and Trends
2.7.1 Gastrointestinal Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Gastrointestinal Drugs Players Market Share by Revenue
2.7.3 Global Gastrointestinal Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Gastrointestinal Drugs Retrospective Market Scenario by Region
3.1 Global Gastrointestinal Drugs Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Gastrointestinal Drugs Global Gastrointestinal Drugs Sales by Region: 2019-2030
3.2.1 Global Gastrointestinal Drugs Sales by Region: 2019-2024
3.2.2 Global Gastrointestinal Drugs Sales by Region: 2025-2030
3.3 Global Gastrointestinal Drugs Global Gastrointestinal Drugs Revenue by Region: 2019-2030
3.3.1 Global Gastrointestinal Drugs Revenue by Region: 2019-2024
3.3.2 Global Gastrointestinal Drugs Revenue by Region: 2025-2030
3.4 North America Gastrointestinal Drugs Market Facts & Figures by Country
3.4.1 North America Gastrointestinal Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Gastrointestinal Drugs Sales by Country (2019-2030)
3.4.3 North America Gastrointestinal Drugs Revenue by Country (2019-2030)
3.4.4 the United States
3.4.5 Canada
3.5 Europe Gastrointestinal Drugs Market Facts & Figures by Country
3.5.1 Europe Gastrointestinal Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Gastrointestinal Drugs Sales by Country (2019-2030)
3.5.3 Europe Gastrointestinal Drugs Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 UK
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Gastrointestinal Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific Gastrointestinal Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Gastrointestinal Drugs Sales by Country (2019-2030)
3.6.3 Asia Pacific Gastrointestinal Drugs Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Gastrointestinal Drugs Market Facts & Figures by Country
3.7.1 Latin America Gastrointestinal Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Gastrointestinal Drugs Sales by Country (2019-2030)
3.7.3 Latin America Gastrointestinal Drugs Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Gastrointestinal Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Gastrointestinal Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Gastrointestinal Drugs Sales by Country (2019-2030)
3.8.3 Middle East and Africa Gastrointestinal Drugs Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Gastrointestinal Drugs Sales by Type (2019-2030)
4.1.1 Global Gastrointestinal Drugs Sales by Type (2019-2024)
4.1.2 Global Gastrointestinal Drugs Sales by Type (2025-2030)
4.1.3 Global Gastrointestinal Drugs Sales Market Share by Type (2019-2030)
4.2 Global Gastrointestinal Drugs Revenue by Type (2019-2030)
4.2.1 Global Gastrointestinal Drugs Revenue by Type (2019-2024)
4.2.2 Global Gastrointestinal Drugs Revenue by Type (2025-2030)
4.2.3 Global Gastrointestinal Drugs Revenue Market Share by Type (2019-2030)
4.3 Global Gastrointestinal Drugs Price by Type (2019-2030)
5 Segment by Application
5.1 Global Gastrointestinal Drugs Sales by Application (2019-2030)
5.1.1 Global Gastrointestinal Drugs Sales by Application (2019-2024)
5.1.2 Global Gastrointestinal Drugs Sales by Application (2025-2030)
5.1.3 Global Gastrointestinal Drugs Sales Market Share by Application (2019-2030)
5.2 Global Gastrointestinal Drugs Revenue by Application (2019-2030)
5.2.1 Global Gastrointestinal Drugs Revenue by Application (2019-2024)
5.2.2 Global Gastrointestinal Drugs Revenue by Application (2025-2030)
5.2.3 Global Gastrointestinal Drugs Revenue Market Share by Application (2019-2030)
5.3 Global Gastrointestinal Drugs Price by Application (2019-2030)
6 Key Companies Profiled
6.1 AstraZeneca
6.1.1 AstraZeneca Corporation Information
6.1.2 AstraZeneca Description and Business Overview
6.1.3 AstraZeneca Gastrointestinal Drugs Sales, Revenue and Gross Margin (2019-2024)
6.1.4 AstraZeneca Gastrointestinal Drugs Product Portfolio
6.1.5 AstraZeneca Recent Developments/Updates
6.2 Sanofi
6.2.1 Sanofi Corporation Information
6.2.2 Sanofi Description and Business Overview
6.2.3 Sanofi Gastrointestinal Drugs Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Sanofi Gastrointestinal Drugs Product Portfolio
6.2.5 Sanofi Recent Developments/Updates
6.3 Bayer
6.3.1 Bayer Corporation Information
6.3.2 Bayer Description and Business Overview
6.3.3 Bayer Gastrointestinal Drugs Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Bayer Gastrointestinal Drugs Product Portfolio
6.3.5 Bayer Recent Developments/Updates
6.4 Pfizer
6.4.1 Pfizer Corporation Information
6.4.2 Pfizer Description and Business Overview
6.4.3 Pfizer Gastrointestinal Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Pfizer Gastrointestinal Drugs Product Portfolio
6.4.5 Pfizer Recent Developments/Updates
6.5 GlaxoSmithKline
6.5.1 GlaxoSmithKline Corporation Information
6.5.2 GlaxoSmithKline Description and Business Overview
6.5.3 GlaxoSmithKline Gastrointestinal Drugs Sales, Revenue and Gross Margin (2019-2024)
6.5.4 GlaxoSmithKline Gastrointestinal Drugs Product Portfolio
6.5.5 GlaxoSmithKline Recent Developments/Updates
6.6 Teva
6.6.1 Teva Corporation Information
6.6.2 Teva Description and Business Overview
6.6.3 Teva Gastrointestinal Drugs Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Teva Gastrointestinal Drugs Product Portfolio
6.6.5 Teva Recent Developments/Updates
6.7 Zeria (Tillotts)
6.6.1 Zeria (Tillotts) Corporation Information
6.6.2 Zeria (Tillotts) Description and Business Overview
6.6.3 Zeria (Tillotts) Gastrointestinal Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Zeria (Tillotts) Gastrointestinal Drugs Product Portfolio
6.7.5 Zeria (Tillotts) Recent Developments/Updates
6.8 Perrigo
6.8.1 Perrigo Corporation Information
6.8.2 Perrigo Description and Business Overview
6.8.3 Perrigo Gastrointestinal Drugs Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Perrigo Gastrointestinal Drugs Product Portfolio
6.8.5 Perrigo Recent Developments/Updates
6.9 Boehringer Ingelheim
6.9.1 Boehringer Ingelheim Corporation Information
6.9.2 Boehringer Ingelheim Description and Business Overview
6.9.3 Boehringer Ingelheim Gastrointestinal Drugs Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Boehringer Ingelheim Gastrointestinal Drugs Product Portfolio
6.9.5 Boehringer Ingelheim Recent Developments/Updates
6.10 Purdue Pharma
6.10.1 Purdue Pharma Corporation Information
6.10.2 Purdue Pharma Description and Business Overview
6.10.3 Purdue Pharma Gastrointestinal Drugs Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Purdue Pharma Gastrointestinal Drugs Product Portfolio
6.10.5 Purdue Pharma Recent Developments/Updates
6.11 C.B. Fleet
6.11.1 C.B. Fleet Corporation Information
6.11.2 C.B. Fleet Gastrointestinal Drugs Description and Business Overview
6.11.3 C.B. Fleet Gastrointestinal Drugs Sales, Revenue and Gross Margin (2019-2024)
6.11.4 C.B. Fleet Gastrointestinal Drugs Product Portfolio
6.11.5 C.B. Fleet Recent Developments/Updates
6.12 Abbott
6.12.1 Abbott Corporation Information
6.12.2 Abbott Gastrointestinal Drugs Description and Business Overview
6.12.3 Abbott Gastrointestinal Drugs Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Abbott Gastrointestinal Drugs Product Portfolio
6.12.5 Abbott Recent Developments/Updates
6.13 Jiangzhong
6.13.1 Jiangzhong Corporation Information
6.13.2 Jiangzhong Gastrointestinal Drugs Description and Business Overview
6.13.3 Jiangzhong Gastrointestinal Drugs Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Jiangzhong Gastrointestinal Drugs Product Portfolio
6.13.5 Jiangzhong Recent Developments/Updates
6.14 Xian-Janssen
6.14.1 Xian-Janssen Corporation Information
6.14.2 Xian-Janssen Gastrointestinal Drugs Description and Business Overview
6.14.3 Xian-Janssen Gastrointestinal Drugs Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Xian-Janssen Gastrointestinal Drugs Product Portfolio
6.14.5 Xian-Janssen Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Gastrointestinal Drugs Industry Chain Analysis
7.2 Gastrointestinal Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Gastrointestinal Drugs Production Mode & Process
7.4 Gastrointestinal Drugs Sales and Marketing
7.4.1 Gastrointestinal Drugs Sales Channels
7.4.2 Gastrointestinal Drugs Distributors
7.5 Gastrointestinal Drugs Customers
8 Gastrointestinal Drugs Market Dynamics
8.1 Gastrointestinal Drugs Industry Trends
8.2 Gastrointestinal Drugs Market Drivers
8.3 Gastrointestinal Drugs Market Challenges
8.4 Gastrointestinal Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business:

Since 2015

Pre Sales Support:

24*7

Post Sales Support:

24*7

Turn Around Time:

Usually 2 Hours

Clients Served:

425 and counting

Clients Assisted:

1750 and counting

Client Types:

Govt Projects, Private Companies, Consultant and Individuals

Payment:

Partners with:

Number of reports:

1,000,000 and counting

Custom Research:

Available

Report Availability:

Global and Regional Reports

Report Delivery Format:

Usually PDF

Security:

Latest Life Science Market Reports

Global Support Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Global Hospital OT and X-Ray, Cathode Room Doors (Hermetically Sealed Door) Market Research Report 2025

Global Children\'s DHA Market Research Report 2025

Global Marine Derived Drugs Market Research Report 2025

Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Payments Accepted From

Connect with us at

Complete Secure Website

#socialicons>a span { top: 0px; left: -100%; -webkit-transition: all 0.3s ease; -moz-transition: all 0.3s ease-in-out; -o-transition: all 0.3s ease-in-out; -ms-transition: all 0.3s ease-in-out; transition: all 0.3s ease-in-out;} #socialicons>ahover div{left: 0px;}